Perrigo (PRGO) Capital Expenditures Growth (1y) (2014 - 2026)
Perrigo (PRGO) Capital Expenditures Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 32.28% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3,566.67% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 113.56% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.95% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -21.54% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -59.55% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -84.04% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -76.65% |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn | -45.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -45.88% |
| Dec 31, 2025 | -28.91% |
| Sep 27, 2025 | -19.19% |
| Jun 28, 2025 | -32.39% |
| Mar 29, 2025 | 1.59% |
| Dec 31, 2024 | 41.20% |
| Sep 28, 2024 | -14.78% |
| Jun 29, 2024 | 42.00% |
| Mar 30, 2024 | 8.19% |
| Dec 31, 2023 | 1.14% |
| Sep 30, 2023 | -47.00% |
| Jul 1, 2023 | 294.17% |
| Apr 1, 2023 | 14.29% |
| Dec 31, 2022 | -36.69% |
| Oct 1, 2022 | 50.75% |
| Jul 2, 2022 | -3,533.33% |
| Apr 2, 2022 | -71.12% |
| Dec 31, 2021 | -36.91% |
| Oct 2, 2021 | -9.95% |
| Jul 3, 2021 | -98.86% |